Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Blood ; 122(18): 3101-10, 2013 Oct 31.
Article de Anglais | MEDLINE | ID: mdl-23982171

RÉSUMÉ

Hydroa vacciniforme-like lymphoma (HVLL) is an Epstein-Barr virus (EBV)-positive T-cell lymphoproliferative disorder of childhood that occurs mainly in Central and South America and Asia. We present the clinicopathological features of 20 Mexican children with HVLL with a median age of 8 years at diagnosis (range, 1-15). All patients presented with skin lesions involving sun-exposed areas, but not exclusively. Fever, lymphadenopathy, and hepatosplenomegaly were often observed. Most patients were treated with immunomodulators and/or immunosuppressive agents, resulting in temporary remission. For 13 patients follow-up was available for a median of 3 years (range, 1 month-13 years). Three patients with long follow-up (9-13 years) are alive with disease. Four patients died, 2 after developing systemic lymphoma. Histologically, the skin showed a predominantly angiocentric and periadnexal Epstein-Barr early RNA+ lymphoid infiltrate with variable atypia and subcutaneous involvement. Fifteen patients showed a T-cell phenotype (12, αß; 2, γδ; 1, silent phenotype) and monoclonal T-cell receptor-γ rearrangements, whereas 6 exhibited a natural killer (NK)-cell phenotype. Four patients had hypersensitivity to mosquito bites. One patient showed both phenotypes. HVLL is an EBV-associated lymphoproliferative disorder of αß-, γδ-, or NK-cell phenotype with a broad clinical spectrum, usually prolonged clinical course, and risk for progression to systemic disease.


Sujet(s)
Infections à virus Epstein-Barr/anatomopathologie , Hydroa vacciniforme/anatomopathologie , Lymphome T cutané/anatomopathologie , Syndromes lymphoprolifératifs/anatomopathologie , Adolescent , Enfant , Enfant d'âge préscolaire , Infections à virus Epstein-Barr/complications , Infections à virus Epstein-Barr/traitement médicamenteux , Femelle , Études de suivi , Herpèsvirus humain de type 4/effets des médicaments et des substances chimiques , Herpèsvirus humain de type 4/génétique , Herpèsvirus humain de type 4/métabolisme , Humains , Hydroa vacciniforme/complications , Hydroa vacciniforme/traitement médicamenteux , Immunohistochimie , Immunosuppresseurs/usage thérapeutique , Hybridation in situ , Nourrisson , Lymphome T cutané/complications , Lymphome T cutané/traitement médicamenteux , Syndromes lymphoprolifératifs/complications , Syndromes lymphoprolifératifs/traitement médicamenteux , Mâle , Mexique , ARN viral/génétique , Récepteurs aux antigènes des cellules T/génétique , Stéroïdes/usage thérapeutique , Lymphocytes T/effets des médicaments et des substances chimiques , Lymphocytes T/métabolisme , Lymphocytes T/virologie , Thalidomide/usage thérapeutique , Protéines virales/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE